Oxyrich

Quick links to important sections

Oxyrich

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxyrich

Quick Facts

Property Description
Active Ingredient Zinc Aspartate (C₈H₁₂N₂O₈Zn)
Form Softgel Capsule (Oral)
Pharmacological Class Essential Mineral Supplement / Trace Element
Common Purpose Nutritional support to address Zinc Deficiency
Origin Synthetic Organic Salt (Chelated Mineral)

Oxyrich: A Trace Element Supplement Defined

Oxyrich is a pharmaceutical preparation classified as an Essential Mineral Supplement, designed to provide the body with the vital trace element zinc for nutritional support. It is typically administered via the Oral route, usually contained within a Softgel Capsule form. The product's classification as a single active ingredient supplement means its role centers on promoting general physiological balance and managing or preventing states of zinc deficiency that can arise from insufficient dietary intake.


Zinc Aspartate: Composition and Enhanced Absorption

The active ingredient in Oxyrich is Zinc Aspartate, which is a synthetic organic salt recognized as a chelated mineral compound where the elemental zinc is chemically bound to the amino acid L-Aspartic Acid. This chelation process is central to the product's design. The chelated structure is engineered for enhanced bioavailability, meaning it facilitates the efficient uptake and absorption of the elemental zinc across the intestinal lining compared to simpler inorganic salts. The specialized Softgel Capsule format, which often contains an oil-based suspension, further aids in this efficient delivery.


General Purpose in Cellular and Metabolic Support

Oxyrich's overarching general purpose is to maintain or restore the body's required zinc levels, which is indispensable for a wide range of biological functions. As an essential mineral, zinc is clinically recognized for acting as a necessary cofactor for hundreds of enzymes, facilitating critical actions like protein synthesis and cell division. By supplying this vital nutrient, Oxyrich contributes to cellular health, generalized metabolic support, and the continuous function of the immune system.

What side effects are possible with Oxyrich?

Oxyrich: Possible Side Effects and Safety Information

The safety profile of this medicine is classified by regulatory authorities based on the frequency and type of adverse reactions observed. The most significant risk associated with treatment is Respiratory Depression, which is a life-threatening, serious adverse reaction that may occur at any time, but is noted as having the highest risk upon the initiation of therapy or following a dosage increase.

The medication also exposes individuals to the risks of Opioid Use Disorder (Addiction), abuse, and misuse, even when administered as prescribed. Prolonged use carries the risk of developing tolerance and physical dependence, which may lead to a withdrawal syndrome if the medication is abruptly discontinued.

Frequency-Classified Adverse Reactions

Adverse reactions are organized into System-Organ Classes (SOCs), including Nervous System Disorders, Gastrointestinal Disorders, and Psychiatric Disorders. The most frequently observed side effects are officially classified as Very Common and Common:

Classification Adverse Reactions (Examples)
Very Common (ge1/10) Constipation, Nausea, Somnolence (Drowsiness), Dizziness, Pruritus (Itching), Headache
Common (ge1/100 to <1/10) Vomiting, Decreased appetite, Anxiety, Insomnia, Tremor, Dry mouth, Fatigue

Special Safety Considerations

Specific safety constraints are noted for certain populations. Caution is advised for the debilitated elderly and patients with impaired renal or hepatic function, as these groups have an increased risk for severe adverse effects, particularly respiratory depression. The concurrent use of this medicine with central nervous system (CNS) depressants carries an explicit regulatory warning due to the heightened risk of profound sedation, coma, and death.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define the overdose profile of Oxyrich (opioid analgesic) by life-threatening clinical manifestations and mandated emergency actions.

Overdose Scope

Category Official Regulatory Statement
Documented Overdose Presentations Life-threatening Respiratory Depression, Profound Sedation or Coma, Miosis (pinpoint pupils), Severe Hypotension, and Hypoxia
Physiological Systems Affected Central Nervous System (CNS), Respiratory System, and Cardiovascular System
Population-Specific Overdose Notes Accidental ingestion by children poses a risk of Fatal Overdose. Increased risk of life-threatening respiratory depression in Elderly or Debilitated Patients

Required Emergency Actions

Category Official Regulatory Statement
Immediate Help Required Seek Immediate Medical Attention for all signs of respiratory depression or profound sedation. Any accidental ingestion requires immediate emergency action.
Antidote and Management Naloxone is the life-saving medication explicitly designated for reversing opioid overdose effects. Treatment requires symptomatic and supportive therapy and establishing adequate respiratory exchange.

The official overdose profile mandates that a suspected overdose is treated as a medical emergency. The risk of fatal overexposure is elevated when the extended-release formulation is manipulated (crushed, chewed, or dissolved), causing rapid drug release, or when co-administered with other CNS depressants. These circumstances trigger an absolute requirement to contact emergency services immediately.

Therapeutic Uses of Oxyrich

Quick Facts

  • Oxyrich is approved for the temporary management of severe pain.
  • It provides symptom relief when non-opioid options are not suitable or have not provided adequate comfort.
  • The medication is indicated for conditions where continuous, around-the-clock opioid analgesia is considered necessary.

What Oxyrich Treats: Main Uses and Benefits

Oxyrich is a prescription medication utilized in adult patients for the management of pain that is classified as severe enough to require treatment with an opioid analgesic. This medication is typically reserved for instances where other therapeutic options, such as non-opioid pain relievers or combination products, have been found to be inadequate or are not tolerated by the patient.

Its clinical role involves contributing to the management of moderate to severe pain when the treating physician determines a continuous, scheduled, and extended treatment period with an opioid is indicated. The benefit provided by the medication is the temporary relief of the intense discomfort associated with such conditions. It is important to note that the use of this drug is subject to stringent guidelines and is not suitable for mild pain or for use on an as-needed basis. Treatment aims to support pain control over a specified duration, with close monitoring of the patient's individual needs.

Eligibility and Restrictions for Use

Official Eligibility Map: Who Can and Cannot Use Oxyrich

Oxyrich (Oxycodone Hydrochloride) is a prescription opioid analgesic whose use is strictly governed by regulatory eligibility rules to mitigate serious risks, primarily life-threatening respiratory depression.

Eligibility Status Population or Condition
Contraindicated (Prohibited) Significant respiratory depression, severe bronchial asthma (in an unmonitored setting), known or suspected gastrointestinal obstruction (including paralytic ileus), or known hypersensitivity to oxycodone.
Approved Population Adults who require continuous, around-the-clock opioid analgesia.
Not Established Use Pediatric patients under 11 years of age (safety and effectiveness are not established).
Conditional Use Elderly/debilitated patients (require close monitoring). Patients with impaired hepatic or renal function (require monitoring and potential dose adjustment).
Restricted Use Pregnancy (prolonged use carries a mandated risk of Neonatal Opioid Withdrawal Syndrome). Lactation (not recommended due to the risk of serious adverse effects on the infant).

This eligibility structure is mandated by government regulatory bodies and explicitly prohibits use in individuals with compromised breathing or obstructed gastrointestinal function. Eligibility for other populations, such as those with organ impairment or those who are elderly, is conditional and requires heightened clinical caution and monitoring, as officially specified in prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This medicine is primarily broken down in the body by a liver enzyme called CYP3A4. Therefore, its concentration can be significantly affected by other medicines that change the activity of this enzyme. These pharmacokinetic interactions can alter the amount of medicine in the bloodstream, potentially leading to increased adverse effects or decreased effectiveness.

Key Interacting Categories and Restrictions

Interaction Mechanism Interacting Medicine Category Regulatory Constraint
Metabolism (CYP3A4) Strong and Moderate CYP3A4 Inhibitors Avoid Concomitant Use
Metabolism (CYP3A4) Strong and Moderate CYP3A4 Inducers Avoid Concomitant Use

Using this medicine concurrently with strong or moderate CYP3A4 inhibitors (which increase its blood levels) or strong or moderate CYP3A4 inducers (which decrease its blood levels) should generally be avoided. Alternative medicinal products with no or minimal CYP3A4-affecting potential should be considered to manage these risks. If avoidance is not possible, a dose adjustment may be required under close medical supervision.

Additionally, this medicine can inhibit efflux transporters, specifically P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP), which may increase the exposure of other medicines that are substrates for these transporters. Separately, females of reproductive potential are advised to use effective non-hormonal contraception during treatment and for one week after the final dose, due to the potential risk to an embryo or fetus.

Mechanism of Action

Oxyrich, formulated for aquatic environments, contains sodium percarbonate, which acts as a molecular oxygen (O2) generator. Upon dissolution in water, the compound undergoes hydrolysis, initiating a chemical decomposition pathway. This reaction yields hydrogen peroxide (H2 O2) and sodium carbonate (Na2 CO3) as primary intermediates. The produced hydrogen peroxide subsequently decomposes into water (H2 O) and free oxygen molecules (O2).

The systemic consequence of this molecular cascade is a net increase in the concentration of dissolved oxygen (DO) within the aqueous medium. This augmentation of DO modulates the systemic physiological environment for aquatic organisms, directly supporting aerobic respiration. Simultaneously, the increased DO concentration shifts the microbial metabolic balance within the aqueous phase, promoting aerobic metabolic processes while selectively suppressing the proliferation of anaerobic microorganisms.

Dosage and Administration Information

How to Use Oxyrich: Official Administration Guidelines

Oxyrich (Oxycodone Extended-Release) is a prescription medication administered exclusively by the oral route. Its usage is governed by protocols to ensure proper, controlled delivery of the drug over a prolonged period.

Standard Dosing and Schedule

Oxyrich is intended only for a continuous, around-the-clock regimen and must not be used as an as-needed (prn) analgesic. The medication is dosed on a 12-hourly schedule (twice daily).

Usage Element Official Label Instruction
Starting Dose (Opioid-Naïve Adult) 10 mg orally every 12 hours.
Titration Increases should be made in 25% to 50% increments, with adjustments typically no more frequent than once every 1-2 days.
Opioid Tolerance Threshold Single doses > 40 mg or total daily doses > 80 mg are reserved for patients with established opioid tolerance.

Administration and Handling

For proper administration, the extended-release tablet or capsule must be swallowed whole and intact with sufficient water. Guidelines strictly prohibit cutting, breaking, chewing, crushing, or dissolving the dosage unit, as this action bypasses the controlled-release mechanism. Some formulations may require intake with food to maintain consistent drug absorption.

Population-Specific Use

Dosage adjustments are mandated for specific populations. For patients who are elderly, debilitated, or who have hepatic or renal impairment, therapy must be initiated conservatively, typically with a reduction to 1/3 to 1/2 of the recommended starting dosage. Use in pediatric patients (age 11 and older) is confined only to those already established as opioid-tolerant.

Discontinuation of Therapy

The medication should never be stopped abruptly. The protocol requires a gradual reduction (tapering) of the dose over time to manage the body's physical dependence on the drug.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Oxyrich

Evidence from Controlled Trials for Severe, Continuous Pain

The primary research base for a medication like Oxyrich, an extended-release opioid formulation, comes from clinical trials that focused on adult patients with severe pain studied under conditions requiring ongoing, scheduled management. The research mostly involved short-term Randomized Controlled Trials (RCTs). These studies were structured to compare the medication to an inactive treatment (placebo) or sometimes to another pain treatment, with research examining how outcomes related to physical discomfort were measured over a defined period.

Researchers often used specialized designs, such as Enriched Enrollment Randomized Withdrawal (EERW) trials. The research describes the observed behavior of the trial populations, finding that participants who continued the active medication discontinued the trial less frequently due to study-defined insufficient pain control compared to the group switched to placebo. Studies contribute to the broader evidence landscape by examining short-term measurements of patient-reported outcomes describing perceived discomfort.

Long-Term Data and Limitations

Key study outcomes examined included measurements of pain intensity or severity and outcomes reflecting daily functioning or activity level. The follow-up durations in the most rigorous controlled studies were limited, focusing on research exploring short-term symptom changes primarily over a period of 12 weeks or less. Results apply only to the populations studied and may not reflect the experiences of individuals with complex co-morbidities.

Long-term effects are not fully established, and information comes from observational settings evaluating daily-life functioning, such as open-label extension studies and patient registry programs. Because these studies do not include a comparison group, the certainty remains low regarding conclusions on sustained effects. Comparative evidence is lacking in large-scale, long-term RCTs that might compare Oxyrich against non-opioid strategies over several years.

Key Studies & References

  1. Opioid Treatments for Chronic Pain (Comparative Effectiveness Review) - NIH (Informs short-term benefits, long-term evidence limitations, and observational risks)
  2. Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched randomized withdrawal trials (Informs short-term efficacy for chronic non-cancer pain up to 3 months)
  3. Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence - PMC - NIH (Informs on EERW methodology, challenges, and high placebo drop-out rates)

Frequently Asked Questions (FAQ)

Common questions about Oxyrich (FAQ)


Q: Are there any serious long-term side effects associated with Oxyrich use?

According to official regulatory documents, the prolonged use of this medication carries the serious risks of developing tolerance, physical dependence, and Opioid Use Disorder (addiction). These risks are noted as present even when the medication is taken exactly as prescribed. Patients are encouraged to discuss these serious risks with a healthcare provider.


Q: Is Oxyrich considered safe for older adults (over 65)?

Official guidance states that caution is necessary when the medication is used in elderly or debilitated individuals. This is due to an increased risk of severe adverse effects, particularly respiratory depression (slow or shallow breathing). Dose adjustments and close monitoring are officially mandated for this population.


Q: Can children or teenagers use Oxyrich?

Safety and effectiveness have not been established for pediatric patients under 11 years of age. For those 11 years and older, the medication's use is strictly conditional and confined only to individuals who have already developed opioid tolerance.


Q: What should I tell my pharmacist about my health history before starting Oxyrich?

Official documentation mandates that individuals must not use this drug if they have certain conditions, such as severe respiratory depression or known gastrointestinal obstruction. Conditional use applies to patients with impaired renal or hepatic function. Official guidance specifies the importance of communicating any existing serious breathing problems or organ impairment to the healthcare team.


Q: Is Oxyrich used for any conditions other than its primary approved use? (Clarification question)

Official documentation strictly indicates the drug only for the management of pain severe enough to require continuous, around-the-clock opioid treatment. The drug is not approved by regulatory bodies for use in any other conditions, which are commonly known as off-label uses.


Q: What is the generic name for Oxyrich?

The active ingredient in this medication is known generically as oxycodone, which is usually found in the formulation as oxycodone hydrochloride.


Q: What part of the body does Oxyrich specifically target to achieve its main effect?

As an opioid analgesic, the drug's principal therapeutic action is centered on the Central Nervous System (CNS). This action helps to produce the intended pain-relieving effect.


Q: How does Oxyrich compare to older treatments for the same condition?

Official research documentation states that comparative evidence is lacking in large-scale, long-term Randomized Controlled Trials (RCTs). These are the types of studies that would be required to compare this drug against non-opioid strategies or older treatments for the same condition.


Q: How long does it usually take for Oxyrich to start working?

Official pharmacokinetic data, which describes how the body processes the drug, specifies the time it takes for the concentration of the medication to reach its highest level in the bloodstream (Tmax). This information describes the theoretical time frame related to the observation of initial effects.


Q: Can Oxyrich cause changes in body weight?

Official adverse reaction tables indicate that a decrease in appetite is classified as a Common side effect associated with the medication’s use.


Q: What impact does Oxyrich have on sleep quality?

Changes in sleep patterns are noted in official product information. Somnolence (drowsiness) is classified as a Very Common adverse reaction, while Insomnia (sleeplessness) is classified as a Common adverse reaction.


Q: Is it normal to feel a change in energy levels when taking Oxyrich?

Yes, official adverse reaction tables indicate that changes in energy levels can occur. Somnolence (drowsiness) is a Very Common reaction, and Fatigue (tiredness) is noted as a Common adverse reaction.


Q: Are headaches and dizziness frequent side effects when first starting the drug?

Dizziness and Headache are both classified as Very Common adverse reactions in official product information. The highest risk for serious adverse effects, such as Respiratory Depression, is noted upon the initiation of therapy or following a dosage increase.


Q: Why do some people experience initial stomach upset with Oxyrich?

Gastrointestinal issues are frequently noted adverse reactions. Official documentation classifies Constipation and Nausea as Very Common, and Vomiting as a Common adverse reaction.


Q: Can Oxyrich cause dental or mouth-related side effects?

Yes, official adverse reaction tables classify Dry mouth as a Common side effect associated with the use of this medication.


Q: Can Oxyrich cause issues with vision or eye health?

Official adverse reactions noted in safety data include visual disturbances and miosis (pinpoint pupils).


Q: Does Oxyrich affect skin sensitivity to the sun?

Yes, official product safety data includes photosensitivity (increased sensitivity to sunlight) as a noted dermatological adverse effect.


Q: What are the potential signs of a serious or allergic reaction to Oxyrich?

The most significant serious risk is life-threatening Respiratory Depression, which can involve slow, shallow breathing and feeling faint. Hypersensitivity reactions (allergic reactions) are also noted, which may involve hives, rash, or swelling of the face, lips, or throat.


Q: Does Oxyrich affect blood pressure or heart rate?

Adverse effects noted in postmarketing reports include cardiovascular symptoms. These may involve hypotension (low blood pressure), hypertension (high blood pressure), bradycardia (slow heart rate), tachycardia (fast heart rate), and palpitations.


Q: What is the expected maximum effect a patient might see from Oxyrich?

Studies examined the medication's effects by assessing outcomes related to physical discomfort, such as measurements of pain intensity or severity. The research also looked at outcomes reflecting daily functioning and activity level.


Q: Does Oxyrich have a high rate of interaction with other prescription medications?

Regulatory guidance explains that the drug’s concentration is significantly affected by any medicine that changes the activity of the liver enzyme CYP3A4. Therefore, the concurrent use with strong or moderate CYP3A4 inhibitors and inducers is generally advised against due to the potential for serious interactions.


Q: Do studies exist for the long-term use of Oxyrich (beyond one year)?

While rigorous controlled trials are typically short-term, long-term information is collected from observational settings. These include open-label extension studies and patient registry programs.


Q: What clinical trials led to the approval of Oxyrich?

The primary research supporting the medication's use comes from short-term Randomized Controlled Trials (RCTs). These studies often utilized specialized designs, such as Enriched Enrollment Randomized Withdrawal (EERW) trials.


Q: What are some common reasons people stop taking Oxyrich?

Common adverse reactions, such as Constipation, Nausea, and Dizziness, may lead to discontinuation. Controlled trials also examined participants discontinuing the study due to insufficient pain control.


Q: How long does Oxyrich stay in your system after stopping treatment?

Official pharmacokinetic data provides the half-life of the active ingredient. The half-life describes the time it takes for the amount of drug in the body to be reduced by half.


Q: Can Oxyrich affect a person’s ability to drive or operate machinery?

Official warnings explicitly state that this medicine may impair the mental and physical abilities needed to perform potentially hazardous activities, such as driving a car or operating machinery.


Q: Is it safe to drink alcohol while using Oxyrich?

Official warnings explicitly prohibit the concurrent use of this medication with alcohol. This combination carries an increased risk of profound sedation, respiratory depression, coma, and death.


Q: Does Oxyrich interact with supplements or herbal remedies?

Official regulatory guidance on interactions applies to any substance, including herbal products, that changes the activity of the liver enzyme CYP3A4. Substances that inhibit or induce this enzyme can significantly affect the medication's concentration in the body.


Q: Is it true that Oxyrich can interact with grapefruit juice?

Yes, official warnings state that grapefruit and grapefruit juice can affect the concentration of the medication. This is because these products can inhibit the enzyme CYP3A4, which is responsible for breaking down the drug.


Q: Are there any known food interactions that affect Oxyrich?

Official administration guidance states that some formulations may require intake with food to maintain consistent drug absorption. Additionally, specific foods like grapefruit or grapefruit juice should generally be avoided because they are known to affect drug metabolism.


Q: What should a patient do if they miss a dose of Oxyrich? (Conceptual question)

Instructions for this type of extended-release formulation typically advise that if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. Instructions for these formulations generally advise against taking a double dose to make up for a missed one, and instead recommend resuming the regular dosing schedule.


Q: Is it better to take Oxyrich in the morning or at night?

The drug is prescribed on a strict 12-hourly schedule to provide continuous pain relief. Official instructions emphasize that maintaining the consistent 12-hour interval between doses is the critical administration condition, regardless of the time of day.


Q: What are the ingredients in Oxyrich tablets besides the active one?

Official labeling lists inactive ingredients, or excipients, used in the tablet formulation. These can include components such as various starches, lactose, microcrystalline cellulose, and magnesium stearate.


Q: Is Oxyrich suitable for people with gluten sensitivities or certain allergies?

Official labeling indicates the drug is contraindicated for individuals with known hypersensitivity to the active ingredient. The inactive ingredients (excipients) used in the tablets, such as lactose and starches, are also listed in official documentation and may be relevant to certain dietary sensitivities.


Q: What is the difference between the 5mg and 10mg strength of Oxyrich?

Official dosing guidelines state that the recommended starting dose for an opioid-naïve adult is 10 mg orally every 12 hours. Other strengths, such as 5 mg tablets, are generally available for dose increases (titration) or to manage individual patient needs.

How should Oxyrich be stored and disposed of?

Official Storage and Disposal Requirements

The regulatory profile for Oxyrich, defined as a prescription opioid analgesic, mandates strict security measures for storage to prevent accidental exposure and misuse.

  • Secure Storage: The medication must be kept in a locked location, inaccessible and out of the sight and reach of children and pets at all times. It must be stored in its original manufacturer container with the safety closure tightly secured.
  • Disposal: Unused or expired medication must follow official government disposal protocols. The preferred method is returning the product to a drug take-back program or utilizing a mail-back envelope. The medicine must not be flushed down the toilet or sink unless specified by the regulatory guidance.

This storage and disposal structure is defined by official mandates that prioritize security and risk mitigation for controlled substances.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxyrich found in:

A-Z Index: